{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T02:44:23Z","timestamp":1782960263120,"version":"3.54.5"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["22120240325"],"award-info":[{"award-number":["22120240325"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82172706"],"award-info":[{"award-number":["82172706"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82373274"],"award-info":[{"award-number":["82373274"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["23S11901300"],"award-info":[{"award-number":["23S11901300"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04496-x","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T09:05:25Z","timestamp":1778490325000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Autophagy-enhanced hybrid pyroptotic vesicles as personalized vaccines for cancer immunotherapy"],"prefix":"10.1186","volume":"24","author":[{"given":"Han","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaye","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengze","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quangang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongguang","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongjian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"issue":"1","key":"4496_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12929-024-01102-w","volume":"32","author":"HC Liao","year":"2025","unstructured":"Liao HC, Liu SJ. Advances in nucleic acid-based cancer vaccines. J Biomed Sci. 2025;32(1):10.","journal-title":"J Biomed Sci"},{"issue":"1","key":"4496_CR2","doi-asserted-by":"publisher","first-page":"4505","DOI":"10.1038\/s41467-023-40207-y","volume":"14","author":"J Meng","year":"2023","unstructured":"Meng J, Lv Y, Bao W, et al. Generation of whole tumor cell vaccine for on-demand manipulation of immune responses against cancer under near-infrared laser irradiation. Nat Commun. 2023;14(1):4505.","journal-title":"Nat Commun"},{"issue":"6","key":"4496_CR3","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s41568-021-00346-0","volume":"21","author":"M Saxena","year":"2021","unstructured":"Saxena M, van der Burg SH, Melief CJM, Bhardwaj N. Therapeutic cancer vaccines. Nat Rev Cancer. 2021;21(6):360\u201378.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"4496_CR4","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41392-023-01674-3","volume":"8","author":"T Fan","year":"2023","unstructured":"Fan T, Zhang M, Yang J, et al. Therapeutic cancer vaccines: advancements, challenges, and prospects. Signal Transduct Target Ther. 2023;8(1):450.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"4496_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13045-025-01670-w","volume":"18","author":"Y Zhou","year":"2025","unstructured":"Zhou Y, Wei Y, Tian X, Wei X. Cancer vaccines: current status and future directions. J Hematol Oncol. 2025;18(1):18.","journal-title":"J Hematol Oncol"},{"issue":"4","key":"4496_CR6","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s41416-023-02327-6","volume":"129","author":"A P\u00e9rez-Ba\u00f1os","year":"2023","unstructured":"P\u00e9rez-Ba\u00f1os A, Gleisner MA, Flores I, et al. Whole tumour cell-based vaccines: tuning the instruments to orchestrate an optimal antitumour immune response. Br J Cancer. 2023;129(4):572\u201385.","journal-title":"Br J Cancer"},{"issue":"11","key":"4496_CR7","doi-asserted-by":"publisher","first-page":"7923","DOI":"10.1021\/acsnano.3c09871","volume":"18","author":"F Zeng","year":"2024","unstructured":"Zeng F, Pan Y, Wu M, et al. Self-Metallized Whole Cell Vaccines Prepared by Microfluidics for Bioorthogonally Catalyzed Antitumor Immunotherapy. ACS Nano. 2024;18(11):7923\u201336.","journal-title":"ACS Nano"},{"issue":"7","key":"4496_CR8","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3390\/vaccines13070672","volume":"13","author":"C Dong","year":"2025","unstructured":"Dong C, Li Z, Tan D, et al. Research and Clinical Progress of Therapeutic Tumor Vaccines. Vaccines (Basel). 2025;13(7):672.","journal-title":"Vaccines (Basel)"},{"key":"4496_CR9","doi-asserted-by":"publisher","first-page":"102329","DOI":"10.1016\/j.coi.2023.102329","volume":"83","author":"G Sari","year":"2023","unstructured":"Sari G, Rock KL. Tumor immune evasion through loss of MHC class-I antigen presentation. Curr Opin Immunol. 2023;83:102329.","journal-title":"Curr Opin Immunol"},{"key":"4496_CR10","doi-asserted-by":"publisher","first-page":"101848","DOI":"10.1016\/j.smim.2023.101848","volume":"71","author":"C Moussion","year":"2024","unstructured":"Moussion C, Delamarre L. Antigen cross-presentation by dendritic cells: A critical axis in cancer immunotherapy. Semin Immunol. 2024;71:101848.","journal-title":"Semin Immunol"},{"key":"4496_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coi.2019.12.005","volume":"64","author":"JD Colbert","year":"2020","unstructured":"Colbert JD, Cruz FM, Rock KL. Cross-presentation of exogenous antigens on MHC I molecules. Curr Opin Immunol. 2020;64:1\u20138.","journal-title":"Curr Opin Immunol"},{"issue":"5","key":"4496_CR12","first-page":"20220170","volume":"4","author":"Y Sun","year":"2024","unstructured":"Sun Y, Hu Y, Geng Y, et al. A self-assembled, genetically engineered, irradiated tumor cell debris vaccine. Explor (Beijing). 2024;4(5):20220170.","journal-title":"Explor (Beijing)"},{"key":"4496_CR13","doi-asserted-by":"publisher","first-page":"101068","DOI":"10.1016\/j.mtbio.2024.101068","volume":"26","author":"J Wang","year":"2024","unstructured":"Wang J, Zhang Z, Liang R, et al. Targeting lymph nodes for enhanced cancer vaccination: From nanotechnology to tissue engineering. Mater Today Bio. 2024;26:101068.","journal-title":"Mater Today Bio"},{"issue":"2","key":"4496_CR14","doi-asserted-by":"publisher","first-page":"EBC20253008","DOI":"10.1042\/EBC20253008","volume":"69","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, Tian M, Tong X, et al. Emerging strategies in lymph node-targeted nano-delivery systems for tumor immunotherapy. Essays Biochem. 2025;69(2):EBC20253008.","journal-title":"Essays Biochem"},{"issue":"1","key":"4496_CR15","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s40164-023-00464-5","volume":"12","author":"M Li","year":"2023","unstructured":"Li M, Jiang P, Yang Y, et al. The role of pyroptosis and gasdermin family in tumor progression and immune microenvironment. Exp Hematol Oncol. 2023;12(1):103.","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"4496_CR16","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40364-025-00771-5","volume":"13","author":"R Miao","year":"2025","unstructured":"Miao R, Wang X, Zhang J, et al. Manipulation of cancer cell pyroptosis for therapeutic approaches: challenges and opportunities. Biomark Res. 2025;13(1):58.","journal-title":"Biomark Res"},{"issue":"1","key":"4496_CR17","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12943-025-02344-4","volume":"24","author":"C Huang","year":"2025","unstructured":"Huang C, Li J, Wu R, et al. Targeting pyroptosis for cancer immunotherapy: mechanistic insights and clinical perspectives. Mol Cancer. 2025;24(1):131.","journal-title":"Mol Cancer"},{"issue":"7","key":"4496_CR18","doi-asserted-by":"publisher","first-page":"948","DOI":"10.20892\/j.issn.2095-3941.2022.0049","volume":"19","author":"W Wang","year":"2022","unstructured":"Wang W, Zhang L, Sun Z. Eliciting pyroptosis to fuel cancer immunotherapy: mechanisms and strategies. Cancer Biol Med. 2022;19(7):948\u201364.","journal-title":"Cancer Biol Med"},{"issue":"1","key":"4496_CR19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12951-024-02354-2","volume":"22","author":"Q Du","year":"2024","unstructured":"Du Q, Luo Y, Xu L, et al. Smart responsive Fe\/Mn nanovaccine triggers liver cancer immunotherapy via pyroptosis and pyroptosis-boosted cGAS-STING activation. J Nanobiotechnol. 2024;22(1):95.","journal-title":"J Nanobiotechnol"},{"issue":"8","key":"4496_CR20","doi-asserted-by":"publisher","first-page":"e492","DOI":"10.1002\/ctm2.492","volume":"11","author":"T Du","year":"2021","unstructured":"Du T, Gao J, Li P, et al. Pyroptosis, metabolism, and tumor immune microenvironment. Clin Transl Med. 2021;11(8):e492.","journal-title":"Clin Transl Med"},{"issue":"39","key":"4496_CR21","doi-asserted-by":"publisher","first-page":"e2408685","DOI":"10.1002\/adma.202408685","volume":"36","author":"Q Cheng","year":"2024","unstructured":"Cheng Q, Zhang T, Wang Q, et al. Photocatalytic Carbon Dots-Triggered Pyroptosis for Whole Cancer Cell Vaccines. Adv Mater. 2024;36(39):e2408685.","journal-title":"Adv Mater"},{"key":"4496_CR22","doi-asserted-by":"publisher","first-page":"628429","DOI":"10.3389\/fimmu.2021.628429","volume":"12","author":"C M\u00fcnz","year":"2021","unstructured":"M\u00fcnz C. The Macroautophagy Machinery in MHC Restricted Antigen Presentation. Front Immunol. 2021;12:628429.","journal-title":"Front Immunol"},{"key":"4496_CR23","doi-asserted-by":"publisher","first-page":"868888","DOI":"10.3389\/fimmu.2022.868888","volume":"13","author":"C M\u00fcnz","year":"2022","unstructured":"M\u00fcnz C. Canonical and Non-Canonical Functions of the Autophagy Machinery in MHC Restricted Antigen Presentation. Front Immunol. 2022;13:868888.","journal-title":"Front Immunol"},{"issue":"22","key":"4496_CR24","doi-asserted-by":"publisher","first-page":"7047","DOI":"10.1158\/1078-0432.CCR-11-0951","volume":"17","author":"Y Li","year":"2011","unstructured":"Li Y, Wang LX, Pang P, et al. Tumor-derived autophagosome vaccine: mechanism of cross-presentation and therapeutic efficacy. Clin Cancer Res. 2011;17(22):7047\u201357.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"4496_CR25","doi-asserted-by":"publisher","first-page":"976","DOI":"10.4161\/onci.20059","volume":"1","author":"Y Yi","year":"2012","unstructured":"Yi Y, Zhou Z, Shu S, et al. Autophagy-assisted antigen cross-presentation: Autophagosome as the argo of shared tumor-specific antigens and DAMPs. Oncoimmunology. 2012;1(6):976\u20138.","journal-title":"Oncoimmunology"},{"key":"4496_CR26","doi-asserted-by":"publisher","first-page":"851166","DOI":"10.3389\/fcell.2022.851166","volume":"10","author":"Y He","year":"2022","unstructured":"He Y, Lu H, Zhao Y. Development of an autophagy activator from Class III PI3K complexes, Tat-BECN1 peptide: Mechanisms and applications. Front Cell Dev Biol. 2022;10:851166.","journal-title":"Front Cell Dev Biol"},{"key":"4496_CR27","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.jconrel.2023.04.031","volume":"357","author":"D Yang","year":"2023","unstructured":"Yang D, Chen M, Sun Y, et al. Microneedle-assisted vaccination combined with autophagy regulation for antitumor immunotherapy. J Control Release. 2023;357:641\u201354.","journal-title":"J Control Release"},{"key":"4496_CR28","doi-asserted-by":"publisher","DOI":"10.1039\/d5mh01048a","author":"Y Zhong","year":"2025","unstructured":"Zhong Y, Qiu Z, Zhang K, et al. Lymph node-targeted metabolic regulatory nanovaccines to boost cancer immunotherapy by potentiating dendritic cell-mediated antigen presentation. Mater Horiz. 2025. https:\/\/doi.org\/10.1039\/d5mh01048a.","journal-title":"Mater Horiz"},{"issue":"34","key":"4496_CR29","doi-asserted-by":"publisher","first-page":"e2207841119","DOI":"10.1073\/pnas.2207841119","volume":"119","author":"J Chen","year":"2022","unstructured":"Chen J, Ye Z, Huang C, et al. Lipid nanoparticle-mediated lymph node-targeting delivery of mRNA cancer vaccine elicits robust CD8(+) T cell response. Proc Natl Acad Sci U S A. 2022;119(34):e2207841119.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4496_CR30","doi-asserted-by":"publisher","first-page":"4371","DOI":"10.1038\/s41467-023-39770-1","volume":"14","author":"V Dasari","year":"2023","unstructured":"Dasari V, McNeil LK, Beckett K, et al. Lymph node targeted multi-epitope subunit vaccine promotes effective immunity to EBV in HLA-expressing mice. Nat Commun. 2023;14(1):4371.","journal-title":"Nat Commun"},{"issue":"12","key":"4496_CR31","doi-asserted-by":"publisher","first-page":"100953","DOI":"10.1016\/j.jpha.2024.02.007","volume":"14","author":"W Guo","year":"2024","unstructured":"Guo W, Zhang X, Wan L, et al. \u03b2-Glucan-modified nanoparticles with different particle sizes exhibit different lymphatic targeting efficiencies and adjuvant effects. J Pharm Anal. 2024;14(12):100953.","journal-title":"J Pharm Anal"},{"issue":"4","key":"4496_CR32","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s12274-019-2301-3","volume":"12","author":"GP Howard","year":"2019","unstructured":"Howard GP, Verma G, Ke X, et al. Critical Size Limit of Biodegradable Nanoparticles for Enhanced Lymph Node Trafficking and Paracortex Penetration. Nano Res. 2019;12(4):837\u201344.","journal-title":"Nano Res"},{"key":"4496_CR33","doi-asserted-by":"publisher","first-page":"841687","DOI":"10.3389\/fphar.2022.841687","volume":"13","author":"W Hong","year":"2022","unstructured":"Hong W, Yang B, He Q, et al. New Insights of CCR7 Signaling in Dendritic Cell Migration and Inflammatory Diseases. Front Pharmacol. 2022;13:841687.","journal-title":"Front Pharmacol"},{"issue":"33","key":"4496_CR34","doi-asserted-by":"publisher","first-page":"e2402199","DOI":"10.1002\/advs.202402199","volume":"11","author":"L Zhou","year":"2024","unstructured":"Zhou L, Zhao L, Wang M, et al. Dendritic Cell-Hitchhiking In Vivo for Vaccine Delivery to Lymph Nodes. Adv Sci (Weinh). 2024;11(33):e2402199.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"4496_CR35","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41467-024-44787-1","volume":"15","author":"CYC Lee","year":"2024","unstructured":"Lee CYC, Kennedy BC, Richoz N, et al. Tumour-retained activated CCR7(+) dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity. Nat Commun. 2024;15(1):682.","journal-title":"Nat Commun"},{"issue":"17","key":"4496_CR36","doi-asserted-by":"publisher","first-page":"e2207017","DOI":"10.1002\/advs.202207017","volume":"10","author":"J Xu","year":"2023","unstructured":"Xu J, Liu H, Wang T, et al. CCR7 Mediated Mimetic Dendritic Cell Vaccine Homing in Lymph Node for Head and Neck Squamous Cell Carcinoma Therapy. Adv Sci (Weinh). 2023;10(17):e2207017.","journal-title":"Adv Sci (Weinh)"},{"issue":"9","key":"4496_CR37","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1038\/s41556-024-01463-2","volume":"26","author":"B Zhou","year":"2024","unstructured":"Zhou B, Jiang ZH, Dai MR, et al. Full-length GSDME mediates pyroptosis independent from cleavage. Nat Cell Biol. 2024;26(9):1545\u201357.","journal-title":"Nat Cell Biol"},{"key":"4496_CR38","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.actbio.2021.09.003","volume":"135","author":"S Hu","year":"2021","unstructured":"Hu S, Ma J, Su C, et al. Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis. Acta Biomater. 2021;135:567\u201381.","journal-title":"Acta Biomater"},{"issue":"17","key":"4496_CR39","doi-asserted-by":"publisher","first-page":"8317","DOI":"10.1039\/D3NR06565K","volume":"16","author":"S He","year":"2024","unstructured":"He S, Zhao Z. Genetically engineered cell-derived nanovesicles for cancer immunotherapy. Nanoscale. 2024;16(17):8317\u201334.","journal-title":"Nanoscale"},{"issue":"7","key":"4496_CR40","doi-asserted-by":"publisher","first-page":"e2302606","DOI":"10.1002\/adhm.202302606","volume":"13","author":"N Zhang","year":"2024","unstructured":"Zhang N, Zeng W, Xu Y, et al. Pyroptosis Induction with Nanosonosensitizer-Augmented Sonodynamic Therapy Combined with PD-L1 Blockade Boosts Efficacy against Liver Cancer. Adv Healthc Mater. 2024;13(7):e2302606.","journal-title":"Adv Healthc Mater"},{"issue":"1","key":"4496_CR41","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41467-023-35917-2","volume":"14","author":"J Lin","year":"2023","unstructured":"Lin J, Sun S, Zhao K, et al. Oncolytic Parapoxvirus induces Gasdermin E-mediated pyroptosis and activates antitumor immunity. Nat Commun. 2023;14(1):224.","journal-title":"Nat Commun"},{"issue":"8","key":"4496_CR42","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/s41565-025-01931-2","volume":"20","author":"Z Li","year":"2025","unstructured":"Li Z, Wang Y, Mo F, et al. Engineering pyroptotic vesicles as personalized cancer vaccines. Nat Nanotechnol. 2025;20(8):1108\u201318.","journal-title":"Nat Nanotechnol"},{"issue":"4","key":"4496_CR43","doi-asserted-by":"publisher","first-page":"e006781","DOI":"10.1136\/jitc-2023-006781","volume":"12","author":"JM Inkol","year":"2024","unstructured":"Inkol JM, Westerveld MJ, Verburg SG, et al. Pyroptosis activates conventional type I dendritic cells to mediate the priming of highly functional anticancer T cells. J Immunother Cancer. 2024;12(4):e006781.","journal-title":"J Immunother Cancer"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04496-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04496-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04496-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T02:03:01Z","timestamp":1782957781000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04496-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4496"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04496-x","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"10 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were conducted following the guidelines of the Animal Ethics Committee of Shanghai Skin Disease Hospital and by the Guide for the Care and Use of Laboratory Animals with the ID number: 2023\u2009\u2212\u2009108 (Animal).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have approved the manuscript and agree with the submission.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"598"}}